Learn, Analyse & Invest
only with

+91

Download Orca

To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Concord Biotech Ltd.

Concord Biotech

₹ 0.00

0.00 (0.00)%

NSE

BSE

Healthcare

Small-cap - With a market cap of ₹107.33 Cr.

EX-Date	Purpose
06 09 2023	Quarterly Results
08 11 2023	Quarterly Results
08 02 2024	Quarterly Results
11 11 2024	Quarterly Results
13 02 2025	Quarterly Results
29 05 2025	Final Dividend & Audited Results
08 08 2025	Quarterly Results
08 08 2025	Quarterly Results
13 11 2025	Quarterly Results
11 02 2026	Quarterly Results

News

08-OCT-2025

Concord Biotech completes NAFDAC inspection at Valthera facility in Gujarat

The inspection was conducted from October 06, 2025 to October 07, 2025

02:39 PM

21-AUG-2025

EU-GMP authorities conduct inspection at Concord Biotech’s API facility in Limbassi

The inspection was carried out from August 18, 2025 to August 21, 2025

03:58 PM

28-JUL-2025

Concord Biotech completes Russian GMP inspection

The inspection was conducted at company’s Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat

03:00 PM

23-JUL-2025

Concord Biotech incorporates wholly owned subsidiary

The newly incorporated entity belongs to Biopharmaceutical Industry

12:30 PM

02-JUL-2025

Concord Biotech makes equity investment of $1,500 in Stellon Biotech Inc

The company proposed to utilize this U.S. Subsidiary to distribute and sell its products in USA

02:12 PM

24-JUN-2025

Concord Biotech gets EIR from USFDA for API facility at Dholka

The said inspection was conducted from April 28, 2025 till May 02, 2025

03:43 PM

09-APR-2025

Concord Biotech gets final approval from USFDA for marketing Teriflunomide Tablets

The approval reinforces company’s capability in successfully developing and commercializing a differentiated product portfolio for the U.S. market

09:02 AM

25-MAR-2025

Concord Biotech commences production of injectable at Valthera facility

This advanced facility has been designed and constructed to adhere to stringent international standards

02:30 PM

04-MAR-2025

Concord Biotech gets nod to make investment of Rs 6.10 crore in Clean Max Everglades

The Board of Directors of the company in their meeting held on March 4, 2025 has approved the same

02:22 PM

14-FEB-2025

Concord Biotech reports marginal decline in Q3 consolidated net profit

Total consolidated income of the company increased marginally by 4% at Rs 258.95 crore for Q3FY25

02:51 PM

17-JAN-2025

Concord biotech to acquire 26% stake of Clean Max from CMEESPL

This strategic investment reinforces the Company’s commitment to environmental responsibility

02:42 PM

23-FEB-2024

Concord Biotech gets GMP for unit II of Gujarat facility

The said inspection has been completed successfully, without any adverse remarks

11:46 AM

18-AUG-2023

Concord Biotech gets EIR from USFDA for Gujarat facility

USFDA had conducted an inspection from June 26, 2023 to June 30, 2023

04:00 PM

31-JUL-2023

Concord Biotech to come out with Rs 1,550 crore IPO on August 4

The equity shares are proposed to be listed on both the bourses, BSE and NSE

12:47 PM